KALA
KALA BIO, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$0.44
$-0.03
(-6.29%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $12.27M | EPS (ttm) | $-5.64 | Current Price | $0.44 |
| Enterprise Value | $12.47M | Forward EPS | $-6.67 | Previous Close | $0.47 |
| P/E Ratio | - | ROA | -65.81% | 52W High | $20.60 |
| Forward P/E | -0.07 | ROE | - | 52W Low | $0.41 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $0.67 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $4.50 |
| P/B Ratio | -0.38 | Profit Margin | - | Volume | 975.38K |
| EV/EBITDA | -0.30 | Current Ratio | 0.74 | Avg Volume | 8.13M |
| EV/Sales | - | Quick Ratio | 0.65 | Beta | -2.44 |
| Employees | 38.00 | Debt/Equity | - | Shares Outstanding | 27.85M |
| Sector | Healthcare | Total Debt | $29.94M | Float Shares | 8.18M |
| Industry | Biotechnology | Total Cash | $21.10M | Short Float | 1.88% |
| Optionable | No | Cash/Share | $2.57 | Short Ratio | 0.18 |
| Dividend Yield | - | Book Value/Share | $-1.17 | % Held by Insiders | 0.23% |
| Target Price | - | Revenue (TTM) | - | % Held by Institutions | 18.48% |